Abstracts - faqs.org

Abstracts

Law

Search abstracts:
Abstracts » Law

Greater predictability may result in patent pools; as the Federal Circuit refines scope of biotech claims, use of collective rights becomes likely

Article Abstract:

The biotechnology industry will inevitably rely on cooperative market-based strategies for technology transfer through such vehicles as patent pools. The fundamental features of such pools include reduced transaction costs, the integrated complementary technologies, the clearance of blocking patent positions and the avoidance of expensive infringement litigation. The consensus among pool participants that individual patent rights will be made available to other members on fair terms guarantees effectiveness.

Author: Sung, Lawrence M., Pelto, Don J.
Publisher: ALM Media, Inc.
Publication Name: The National Law Journal
Subject: Law
ISSN: 0162-7325
Year: 1998
Biotechnology industry, Biotechnology industries

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Labeling for generic: no infringement; 2d Circuit recently held that there was no copyright violation when brand-name's user's guide and audiotape were copied

Article Abstract:

SmithKline Beecham Consumer Healthcare LP v. Watson Pharmaceuticals Inc, a US Court of Appeals for the 2d Circuit case holding that a generic drug manufacturer held no copyright infringement liability for the using the same labeling the FDA had approved for use with the brand-name drug, is discussed.The Drug Price Competition and Patent Term Restoration Act of 1984 requires the same labeling for both drugs.

Author: Sung, Lawrence M., Loren, Lydia P.
Publisher: ALM Media, Inc.
Publication Name: The National Law Journal
Subject: Law
ISSN: 0162-7325
Year: 2000
Cases, Copyright, Copyrights, Labeling

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Patent law; generic drug rulings

Article Abstract:

The Federal Circuit's holding in Bayer AG v. Elan Pharmaceutical Research Corp ruling for generic drug companies regarding infringement in generic drug matters is discussed.The specification for the generic drug submitted to the FDA is adequate evidence to determine such infringement, according to the court.

Author: Ward, Jeffrey S.
Publisher: ALM Media, Inc.
Publication Name: The National Law Journal
Subject: Law
ISSN: 0162-7325
Year: 2000

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Intellectual property, Generic drugs
Similar abstracts:
  • Abstracts: FMLA calls for proper designation; the Family and Medical Leave Act requires employers to classify absences as FMLA leave and to notify employees in writing
  • Abstracts: Naming children as beneficiaries of retirement plan assets. New and expanded uses of viatical settlements in insurance planning
  • Abstracts: 'Samara' expands trade dress protection for clothes; the 2d Circuit found the overall design of several nondistinctive features inherently distinctive
  • Abstracts: Takeover specialists; why many litigators hand their cases to High Court pros. A marriage proposal; Vermont Supreme Court seeks common ground on gay unions
  • Abstracts: Unpredictability factor narrows biotech patents; courts have held biotechnology inventions nonenabled when results are deemed unreliable
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.